184 related articles for article (PubMed ID: 31003561)
1. In Vitro Anticancer Properties of Copper Metallodendrimers.
Hołota M; Magiera J; Michlewska S; Kubczak M; Del Olmo NS; García-Gallego S; Ortega P; de la Mata FJ; Ionov M; Bryszewska M
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31003561
[TBL] [Abstract][Full Text] [Related]
2. Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.
Sanz Del Olmo N; Maroto-Díaz M; Gómez R; Ortega P; Cangiotti M; Ottaviani MF; de la Mata FJ
J Inorg Biochem; 2017 Dec; 177():211-218. PubMed ID: 29031179
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.
Michlewska S; Kubczak M; Maroto-Díaz M; Sanz Del Olmo N; Ortega P; Shcharbin D; Gomez Ramirez R; Javier de la Mata F; Ionov M; Bryszewska M
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450702
[TBL] [Abstract][Full Text] [Related]
4. Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An
Canonico B; Carloni R; Sanz Del Olmo N; Papa S; Nasoni MG; Fattori A; Cangiotti M; de la Mata FJ; Ottaviani MF; García-Gallego S
Mol Pharm; 2020 Jul; 17(7):2691-2702. PubMed ID: 32484691
[TBL] [Abstract][Full Text] [Related]
5. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models.
Hołota M; Michlewska S; Garcia-Gallego S; Del Olmo NS; Ortega P; Bryszewska M; de la Mata FJ; Ionov M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835489
[TBL] [Abstract][Full Text] [Related]
6. Elaborated study of Cu(II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents.
Carloni R; Sanz Del Olmo N; Canonico B; Montanari M; Ciacci C; Ambrosi G; de la Mata FJ; Ottaviani MF; García-Gallego S
Eur J Med Chem; 2021 Apr; 215():113292. PubMed ID: 33631696
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium dendrimers as carriers for anticancer siRNA.
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Loznikova S; Shcharbin D; Maly M; Ramirez RG; de la Mata FJ; Bryszewska M
J Inorg Biochem; 2018 Apr; 181():18-27. PubMed ID: 29353086
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium dendrimers against acute promyelocytic leukemia:
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
[TBL] [Abstract][Full Text] [Related]
9. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models.
Sanz Del Olmo N; Carloni R; Bajo AM; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
Nanoscale; 2019 Jul; 11(28):13330-13342. PubMed ID: 31271405
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.
Michlewska S; Ionov M; Szwed A; Rogalska A; Sanz Del Olmo N; Ortega P; Denel M; Jacenik D; Shcharbin D; de la Mata FJ; Bryszewska M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526993
[TBL] [Abstract][Full Text] [Related]
11. Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells.
Sanz Del Olmo N; Holota M; Michlewska S; Gómez R; Ortega P; Ionov M; de la Mata FJ; Bryszewska M
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32748821
[TBL] [Abstract][Full Text] [Related]
12. Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.
Galan M; Sanchez-Rodriguez J; Cangiotti M; Garcia-Gallego S; Jimenez JL; Gomez R; Ottaviani MF; Munoz-Fernandez MA; de la Mata FJ
Curr Med Chem; 2012; 19(29):4984-94. PubMed ID: 22963631
[TBL] [Abstract][Full Text] [Related]
13. Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA.
Rodríguez-Prieto T; Michlewska S; Hołota M; Ionov M; de la Mata FJ; Cano J; Bryszewska M; Gómez R
J Inorg Biochem; 2021 Oct; 223():111540. PubMed ID: 34273717
[TBL] [Abstract][Full Text] [Related]
14. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action.
Dzmitruk V; Szulc A; Shcharbin D; Janaszewska A; Shcharbina N; Lazniewska J; Novopashina D; Buyanova M; Ionov M; Klajnert-Maculewicz B; Gómez-Ramirez R; Mignani S; Majoral JP; Muñoz-Fernández MA; Bryszewska M
Int J Pharm; 2015 May; 485(1-2):288-94. PubMed ID: 25796120
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activities of chloropyridylimineplatinum(II) and chloropyridyliminecopper(II) surface-functionalized poly(amidoamine) dendrimers.
Zhao X; Loo SC; Lee PP; Tan TT; Chu CK
J Inorg Biochem; 2010 Feb; 104(2):105-10. PubMed ID: 19942292
[TBL] [Abstract][Full Text] [Related]
16. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
Agarwal A; Gupta U; Asthana A; Jain NK
Biomaterials; 2009 Jul; 30(21):3588-96. PubMed ID: 19344947
[TBL] [Abstract][Full Text] [Related]
17. Thermoresponsive dendrimers based on oligoethylene glycols: design, synthesis and cytotoxic activity against MCF-7 breast cancer cells.
Abdel-Rahman MA; Al-Abd AM
Eur J Med Chem; 2013 Nov; 69():848-54. PubMed ID: 24121308
[TBL] [Abstract][Full Text] [Related]
18. Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities.
El Brahmi N; El Kazzouli S; Mignani SM; Essassi el M; Aubert G; Laurent R; Caminade AM; Bousmina MM; Cresteil T; Majoral JP
Mol Pharm; 2013 Apr; 10(4):1459-64. PubMed ID: 23410260
[TBL] [Abstract][Full Text] [Related]
19. Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells.
Pedziwiatr-Werbicka E; Fuentes E; Dzmitruk V; Sánchez-Nieves J; Sudas M; Drozd E; Shakhbazau A; Shcharbin D; de la Mata FJ; Gomez-Ramirez R; Munoz-Fernandez MA; Bryszewska M
Colloids Surf B Biointerfaces; 2013 Sep; 109():183-9. PubMed ID: 23643914
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells.
Michlewska S; Maroto M; Hołota M; Kubczak M; Sanz Del Olmo N; Ortega P; Shcharbin D; de la Mata FJ; Bryszewska M; Ionov M
Dalton Trans; 2021 Jul; 50(27):9500-9511. PubMed ID: 34254615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
